- 2007 HCPCS S2107
- Tumor-infiltrating lymphocyte therapy) per course of treatment adoptive immunotherapy i.e. development of specific anti-tumor reactivity (e.g.
- This is the 2007 version of HCPCS S2107 - please refer to the 2016 HCPCS code set for the latest version.
S2103 S2112 
